News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing
Vivek Subbiah/LinkedIn
Apr 20, 2025, 09:19

Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared an article by Richard A. Furie, et al. on X:

“Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis:

Obinutuzumab = a humanized type II anti-CD20 monoclonal antibody approved in CLL.

A nice example of drug repurposing.”

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.

Authors: Richard A. Furie, et al.

Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing

Active Lupus Nephritis cancer CLL drug repurposing early-phase drug development fight against cancer Global fight against cancer Monoclonal Antibody Obinutuzumab OncoDaily Oncology Sarah Cannon Research Institute Vivek Subbiah
Special Coverage
Voices
Aug 24, 2025, 15:32
Honoring Ryan and Haley for Their Lifesaving Support - ALSAC
Voices
Aug 24, 2025, 15:27
Ed Kim: Unveiling the Spirit of Life Statue at City of Hope Orange County
Voices
Aug 24, 2025, 15:26
IASLC Congratulates Pedro Rocha: 2025 Young Investigator Awardee for SCLC Biomarker Research
Blog Posts
Aug 24, 2025, 15:23
Kefah Mokbel Shares a Study on Patient Attitudes Toward AI in Cancer Care
Voices
Aug 24, 2025, 15:19
Taiho Oncology’s Support Fuels Our Fight Against Colorectal Cancer - Fight Colorectal Cancer
Blog Posts
Aug 24, 2025, 15:15
Marianne Sarcich: Johns Hopkins Metastatic Breast Cancer Couples Retreat
Societies
Aug 24, 2025, 15:14
The 8th Episode of the APAC Lung Cancer Consensus Video Series - ASPIRE for Lung Cancer
Voices
Aug 24, 2025, 15:10
Sahar Mansour: Contrast Mammography Workshop at the Breast Cancer Hospital, NCI-Cairo University
Voices
Aug 24, 2025, 15:08
George Kumar: Tamoxifen and PI3K Activation in Uterine Cancer
Voices
Aug 24, 2025, 15:06
Real Change Happens When Passionate People Step up to Lead - American Cancer Society
Voices
Aug 24, 2025, 14:59
Dora Vallejo-Ardila: A Global Shift from Promise to Practice in Precision Oncology
Voices
Aug 24, 2025, 14:48
Olubukola Ayodele: The Long Journey from Lab Discovery to Cancer Treatment